1. A novel B- and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus

Mohammad Mostafa Pourseif, Gholamali Moghaddam*, Hossein Daghighkia, Ahmad Nematollahi, Yadollah Omidi*

Bioimpacts. 2018;8(1): 39-52. doi: 10.15171/bi.2018.06

PMCID: PMC5915707 PMID: 29713601 Scopus ID: 85044310762

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Original Research

2. In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens

Sepideh Parvizpour, Jafar Razmara, Mohammad M. Pourseif, Yadollah Omidi*

Bioimpacts. 2019;9(1): 45-56. doi: 10.15171/bi.2019.06

PMCID: PMC6378095 PMID: 30788259 Scopus ID: 85060470196

Article

PDF

Full Text

XML

Cited By:

Using immunoinformatic tools, a multi-epitope peptide vaccine (consisting of CD8+cytotoxic T lymphocytes epitopes, helper epitopes and adjuvant) was designed to combat the triple-negative breast cancer. The vaccine showed acceptable immunogenicity and potential to stimulate both cellular and humoral immune responses.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons